Bypassing the Weight Loss Narrative : Through secondary analyses, Northwestern scientists proved a vital mechanistic point: weight loss alone does not explain the increased risk of low blood pressure
Hilchie AL, Doucette CD, Pinto DM, Patrzykat A, Douglas S, Hoskin DW
This may reflect a need for enhanced provider familiarity with tirzepatide for primary care providers
Injectable GLP-1 Medications The established injectable options are semaglutide (Ozempic for type 2 diabetes, Wegovy for weight loss) and tirzepatide (Mounjaro for type 2 diabetes, Zepbound for weight loss), both given as once-weekly subcutaneous injections
Oral Wegovy Cost and Insurance Coverage Klinic works with most major insurance plans to facilitate oral wegovy prescriptions
This Insight is the second of a series exploring GLP-1 manufacturing, evidence, product pipeline, and coverage